CVAid Medical has developed an AI-driven platform that enables neurological examinations from smartphone video and voice recordings, processing image and audio data in the cloud with in-house algorithms for real-time analysis and comparison with stored medical records. The system provides clinicians with immediate diagnostic output on whether a patient has had a stroke and an assessment of severity, plus tools to support rapid treatment decisions. The technology is also designed for use by non-professionals (e.g., retirement-home staff or family members) to enable early detection, coordinate evacuation, and ready hospital teams before ambulance arrival. The company has conducted clinical trials at hospitals in Israel and Europe and has examined hundreds of patients. Led by CEO Oren Dror and founded in 2018, CVAid plans to expand operations and accelerate its business reach using the new funds.

Total raised

$4M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2022